冠心病患者血浆凝血、纤溶检测指标与低密度脂蛋白水平的相关性研究 Relationship of serum low density lipoprotein to coagulation and fibrinolysis levels in coronary artery disease patients
覃方生,陈聿峰,覃宋强,等.冠心病患者血栓调节蛋白与C反应蛋白的相关性研究[J].广西医学,2015,37(11):1 659-1 660.Qin FS,Chen YF,Qin SQ,et al.Correlation between thrombomodulin and C reactive protein in patients with coronary heart disease[J].Guangxi Medicine,2015,37(11):1 659-1 660.
[2]
黄玉艳,黄全跃.血浆凝血酶-抗凝血酶Ⅲ复合物水平对非瓣膜性房颤和慢性心力衰竭患者临床意义[J].实用预防医学,2012,19(5):752-754.Huang YY,Huang QY.Study on the clinic signifieance of plasma thrombin-antithrombinⅢcomplexs level in patients with non-valvular atrial fibrillation and chronic heart failure[J].Practical Preventive Medicine,2012,19(5):752-754.
[3]
Fadel FL,Elshamaa MF,Abdel-Rahman SM,et al.Coagulation,thrombophilia and patency of arteriovenous fistula in children undergoing haemodialysis com-pared with healthy volunteers:a prospective analysis[J].Blood Coagul Fibrinolysis,2016,27(2):190-198.
[4]
Valente-Acosta B,Banos-Gonzalez MA,Pena-Duque MA,et al.Association between stable coronary artery disease and in vivo thrombin generation[J].Cardiol Res Pract,2016,2016:5149825.
[5]
Negreva M,Georgiev S,Prodanova K,et al.Early changes in the antithrombin and thrombin-antithrombin complex in patients with paroxysmal atrial fibrillation[J].Cardiol Res,2016,7(3):89-94.
[6]
Steinberg D.The LDL modification hypothesis of ath-erogenesis:an update[J].J Lipid Res,2009,50(Suppl):S376-S381.
[7]
熊旭光,唐其柱,刘文卫.凝血酶-抗凝血酶复合物及D-二聚体在冠心病早期诊断中的价值[J].实用老年医学,2015,29(2):131-133.Xiong XG,Tang QZ,Liu WW.Value of thrombin-antithrombin complex,D-dimer in the early diagnosis for coronary artery disease[J].Pract Geriatr,2015,29(2):131-133.
[8]
Wada T,Gando S,Mizugaki A,et al.Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis Lead to organ dysfunction[J].Thromb Res,2013,132(1):e64-e69.
[9]
Conway EM.Thrombomodulin and its role in inflammation[J].Semin Immunopathol,2012,34(1):107-125.
[10]
苑姗姗,荣瑗瑗.血栓调节蛋白与冠心病的研究进展[J].中国循证心血管医学杂志,2015,7(4):568-571.Yuan SS,Rong YY.Research progress of thrombomodulin and coronary heart disease[J].Chin J Evid Based Cardiovasc Med,2015,7(4):568-571.
[11]
李雪美,江淼,赵益明.血管性血友病因子的研究进展[J].中国实验血液学杂志,2013,21(3):801-805.Li XM,Jiang M,Zhao YM.Research advance in von Willebrand factor[J].Journal of Experimental Hematology,2013,21(3):801-805.
[12]
吕永楠,任玮,陈晶晶,等.急性心肌梗死患者血栓标志物水平变化及意义[J].微循环学杂志,2017,27(3):43-46.LüYN,Ren W,Chen JJ,et al.Clinical significance of blood coagulation biomarkers in patients with acute myocardial infarction[J].Chinese Journal of Microcirculation,2017,27(3):43-46.
[13]
Borissoff JI,Joosen IA,Versteylen MO,et al.Acce-lerated in vivo thrombin formation independently predicts the presence and severity of CT angiographic coronary atherosclerosis[J].JACC Cardiovasc Imaging,2012,5(12):1 201-1 210.
[14]
John S,Drobnik W,Lackner K,et al.Soluble thrombomodulin and endothelial dysfunction in early atherosclerosis[J].Lancet,1999,354(9 190):1 647-1 647.
